Akebia Therapeutics Inc. buy Piper Sandler
Start price
31.05.23
/
50%
€0.92
Target price
31.05.24
-
Performance (%)
34.78%
Price
25.04.24
€1.24
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler for Akebia Therapeutics Inc. has seen massive gains of 34.78%. This prediction currently runs until 31.05.24. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | -3.715% | -3.715% |
| iShares Core DAX® | 1.051% | -1.833% |
| iShares Nasdaq 100 | -0.547% | -3.738% |
| iShares Nikkei 225® | -1.778% | -8.115% |
| iShares S&P 500 | 0.002% | -2.226% |
Comments by Piper_Sandler for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating.
Ratings data for AKBA provided by MarketBeat